CLINICAL TRIALS PROFILE FOR KAZANO
✉ Email this page to a colleague
All Clinical Trials for KAZANO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01890122 ↗ | Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes | Completed | Takeda | Phase 3 | 2013-09-01 | The purpose of this study is to evaluate the efficacy and safety of alogliptin and metformin fixed-dose combination (FDC) as compared with alogliptin alone or metformin alone on Type 2 Diabetes Mellitus (T2DM). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for KAZANO
Condition Name
Clinical Trial Locations for KAZANO
Clinical Trial Progress for KAZANO
Clinical Trial Phase
Clinical Trial Sponsors for KAZANO
Sponsor Name